DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Tranxene (Clorazepate Dipotassium) - Summary

 

-- advertisement --

TRANXENE SUMMARY

TRANXENE (clorazepate dipotassium) is a benzodiazepine.

TRANXENE is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic.

TRANXENE tablets are indicated as adjunctive therapy in the management of partial seizures.

The effectiveness of TRANXENE tablets in long-term management of anxiety, that is, more than 4 months, has not been assessed by systematic clinical studies. Long-term studies in epileptic patients, however, have shown continued therapeutic activity. The physician should reassess periodically the usefulness of the drug for the individual patient.

TRANXENE tablets are indicated for the symptomatic relief of acute alcohol withdrawal.

TRANXENE NEWS HIGHLIGHTS

Published Studies Related to Tranxene (Clorazepate)

Clorazepate dipotassium versus midazolam for premedication in clear corneal cataract surgery. [2003.10]

Efficacy and safety of trazodone versus clorazepate in the treatment of HIV-positive subjects with adjustment disorders: a pilot study. [1999.09]

Comparative study of the efficacy and safety of trazodone versus clorazepate in the treatment of adjustment disorders in cancer patients: a pilot study. [1999]

Effects of clorazepate, diazepam, and oxazepam on a laboratory measurement of aggression in men. [1998.07]

Preoperative anxiolysis with minimal sedation in elderly patients: bromazepam or clorazepate-dipotassium? [1998.01]

more>>

Page last updated: 2006-01-31

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008